BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18825593)

  • 1. Neuroblastoma and opsoclonus-myoclonus-ataxia syndrome--clinical and pathological characteristics.
    Stefanowicz J; Izycka-Swieszewska E; Drozyńska E; Pienczk J; Połczyńska K; Czauderna P; Sierota D; Bień E; Stachowicz-Stencel T; Kosiak W; Balcerska A
    Folia Neuropathol; 2008; 46(3):176-85. PubMed ID: 18825593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early Detection and Treatment of Neuroblastic Tumor with Opsoclonus-Myoclonus Syndrome Improve Neurological Outcome: A Review of Five Cases at a Single Institution in Japan.
    Takama Y; Yoneda A; Nakamura T; Nakaoka T; Higashio A; Santo K; Kuki I; Kawawaki H; Tomiwa K; Hara J
    Eur J Pediatr Surg; 2016 Feb; 26(1):54-9. PubMed ID: 26409265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Opsoclonus-myoclonus in children associated or not with neuroblastoma.
    Krug P; Schleiermacher G; Michon J; Valteau-Couanet D; Brisse H; Peuchmaur M; Sarnacki S; Martelli H; Desguerre I; Tardieu M
    Eur J Paediatr Neurol; 2010 Sep; 14(5):400-9. PubMed ID: 20110181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comprehensive treatment of neuroblastoma in children associated with opsoclonus-myoclonus-ataxia syndrome].
    Zhao W; Sun Q; Xie Y; Hua Y; Xiong H; Jia J; Lu X
    Zhonghua Er Ke Za Zhi; 2014 Jul; 52(7):540-3. PubMed ID: 25224062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses.
    Ertle F; Behnisch W; Al Mulla NA; Bessisso M; Rating D; Mechtersheimer G; Hero B; Kulozik AE
    Pediatr Blood Cancer; 2008 Mar; 50(3):683-7. PubMed ID: 17226843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Opsoclonus-myoclonus syndrome in a 2 year old boy with prenatally diagnosed retroperitoneal tumour].
    Jamroz E; Głuszkiewicz E; Madziara W; Kiełtyka A
    Med Wieku Rozwoj; 2011; 15(2):151-6. PubMed ID: 22002047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Opsoclonus myoclonus syndrome secondary to abdominal neuroblastoma. Presentation of a pediatric clinical case].
    Urman G; Leivi M; Chamorro N; García B; Callea A; Grosman A
    Arch Argent Pediatr; 2019 Dec; 117(6):e651-e654. PubMed ID: 31758904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Whole-body magnetic resonance imaging in a patient with an occult abdominal neuroblastoma and opsoclonus-myoclonus syndrome].
    Miras Azcón F; Culiañez Casas M; Pastor Pons E
    Radiologia; 2014; 56(6):e54-7. PubMed ID: 22818898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial.
    de Alarcon PA; Matthay KK; London WB; Naranjo A; Tenney SC; Panzer JA; Hogarty MD; Park JR; Maris JM; Cohn SL
    Lancet Child Adolesc Health; 2018 Jan; 2(1):25-34. PubMed ID: 29376112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opsoclonus-Myoclonus-Associated Neuroblastoma With Bone Marrow Metastases: What Would Be the Best Treatment Option?
    Gizhlaryan M; Aghabekyan T; Arakelyan T; Petrosyan M; Iskanyan S; Tamamyan G; Sargsyan L; Papyan R
    Oncology (Williston Park); 2021 Oct; 35(10):665-667. PubMed ID: 34677924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Opsoclonus-myoclonus syndrome associated with non-metastatic neuroblastoma. Long-term survival. Study of the French Society of Pediatric Oncologists].
    Plantaz D; Michon J; Valteau-Couanet D; Coze C; Chastagner P; Bergeron C; Nelken B; Martelli H; Peyroulet MC; Carpentier AF; Armari-Alla C; Pagnier A; Rubie H
    Arch Pediatr; 2000 Jun; 7(6):621-8. PubMed ID: 10911528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifactorial analysis of opsoclonus-myoclonus syndrome etiology ("Tumor" vs. "No tumor") in a cohort of 356 US children.
    Pranzatelli MR; Tate ED; McGee NR
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27097. PubMed ID: 29727049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab for treatment of opsoclonus-myoclonus syndrome in neuroblastoma.
    Burke MJ; Cohn SL
    Pediatr Blood Cancer; 2008 Mar; 50(3):679-80. PubMed ID: 16900484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome.
    De Grandis E; Parodi S; Conte M; Angelini P; Battaglia F; Gandolfo C; Pessagno A; Pistoia V; Mitchell WG; Pike M; Haupt R; Veneselli E
    Neuropediatrics; 2009 Jun; 40(3):103-11. PubMed ID: 20020394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsoclonus-myoclonus-ataxia syndrome in neuroblastoma: clinical outcome and antineuronal antibodies-a report from the Children's Cancer Group Study.
    Rudnick E; Khakoo Y; Antunes NL; Seeger RC; Brodeur GM; Shimada H; Gerbing RB; Stram DO; Matthay KK
    Med Pediatr Oncol; 2001 Jun; 36(6):612-22. PubMed ID: 11344492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-related opsoclonus-myoclonus-ataxia syndrome: report on two cases.
    Kanjanasut N; Phanthumchinda K; Bhidayasiri R
    Clin Neurol Neurosurg; 2010 Sep; 112(7):572-4. PubMed ID: 20427123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The opsoclonus–myoclonus syndrome.
    Sahu JK; Prasad K
    Pract Neurol; 2011 Jun; 11(3):160-6. PubMed ID: 21551110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological features of neuroblastic tumors with opsoclonus-myoclonus-ataxia syndrome: Follicular structure predicts a better neurological outcome.
    Fukushima H; Inoue T; Takama Y; Ishii N; Okuno T; Kobayashi Y; Yoneda A; Nakamura T; Kuki I; Hara J
    Pathol Int; 2017 Oct; 67(10):503-509. PubMed ID: 28971571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Refractory diarrhea: A paraneoplastic syndrome of neuroblastoma.
    Han W; Wang HM
    World J Gastroenterol; 2015 Jul; 21(25):7929-32. PubMed ID: 26167095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroblastoma found in a 4-year-old after rituximab therapy for opsoclonus-myoclonus.
    Chang BH; Koch T; Hopkins K; Malempati S
    Pediatr Neurol; 2006 Sep; 35(3):213-5. PubMed ID: 16939863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.